Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Pituitary Society update to acromegaly management guidelines
Maria Fleseriu, Beverly M. K. Biller, Pamela U. Freda, et al.
Pituitary (2020) Vol. 24, Iss. 1, pp. 1-13
Open Access | Times Cited: 249

Showing 1-25 of 249 citing articles:

Acromegaly: pathogenesis, diagnosis, and management
Maria Fleseriu, Fabienne Langlois, Dawn Shao Ting Lim, et al.
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 11, pp. 804-826
Closed Access | Times Cited: 133
Diagnosis and Management of Pituitary Adenomas
Nicholas A. Tritos, Karen K. Miller
JAMA (2023) Vol. 329, Iss. 16, pp. 1386-1386
Closed Access | Times Cited: 130
Consensus on criteria for acromegaly diagnosis and remission
Andrea Giustina, Nienke R. Biermasz, Felipe F. Casanueva, et al.
Pituitary (2023)
Open Access | Times Cited: 79
Diagnosis and Treatment of Acromegaly: An Update
Nazanin Ershadinia, Nicholas A. Tritos
Mayo Clinic Proceedings (2022) Vol. 97, Iss. 2, pp. 333-346
Open Access | Times Cited: 76
COVID-19 and the pituitary
Stefano Frara, Agnese Allora, Laura Castellino, et al.
Pituitary (2021) Vol. 24, Iss. 3, pp. 465-481
Open Access | Times Cited: 92
The Future of Somatostatin Receptor Ligands in Acromegaly
Mônica R. Gadelha, Luiz Eduardo Wildemberg, Leandro Kasuki
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 2, pp. 297-308
Open Access | Times Cited: 61
Transient Permeation Enhancer® (TPE®) technology for oral delivery of octreotide: a technological evaluation
David J. Brayden, Sam Maher
Expert Opinion on Drug Delivery (2021) Vol. 18, Iss. 10, pp. 1501-1512
Open Access | Times Cited: 59
Pasireotide—a novel somatostatin receptor ligand after 20 years of use
Marek Bolanowski, Marcin Kałużny, Przemysław Witek, et al.
Reviews in Endocrine and Metabolic Disorders (2022) Vol. 23, Iss. 3, pp. 601-620
Open Access | Times Cited: 39
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers
Andrea Giustina, Meliha Melin Uygur, Stefano Frara, et al.
Pituitary (2023) Vol. 26, Iss. 5, pp. 583-596
Open Access | Times Cited: 34
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)
Andrea Giustina, Meliha Melin Uygur, Stefano Frara, et al.
Pituitary (2024) Vol. 27, Iss. 4, pp. 381-388
Open Access | Times Cited: 15
Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine
Mônica R. Gadelha, Alessandra Casagrande, Christian J. Strasburger, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 110, Iss. 1, pp. 228-237
Open Access | Times Cited: 14
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases
Márta Korbonits, Joanne Blair, Anna Bogusławska, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 5, pp. 290-309
Open Access | Times Cited: 11
Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management
Daniela Espósito, César Luiz Boguszewski, Annamaria Colao, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 9, pp. 541-552
Closed Access | Times Cited: 9
More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY
Maria Fleseriu, Dagmar Führer‐Sakel, A. J. van der Lely, et al.
European Journal of Endocrinology (2021) Vol. 185, Iss. 4, pp. 525-538
Open Access | Times Cited: 54
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States
Maria Fleseriu, Ariel L. Barkan, Maria del Pilar Schneider, et al.
Pituitary (2022) Vol. 25, Iss. 2, pp. 296-307
Open Access | Times Cited: 30
Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases
Marta Araujo‐Castro, Betina Biagetti, Edelmiro Menéndez Torre, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. e2178-e2187
Open Access | Times Cited: 8
Pasireotide in the Personalized Treatment of Acromegaly
Manel Puig‐Domingo, Ignacio Bernabéu, Antonio Picó, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 39
Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial
Maria Fleseriu, Alexander Dreval, Irina Bondar, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 10, Iss. 2, pp. 102-111
Open Access | Times Cited: 39
Acromegaly and cardiovascular outcomes: a cohort study
Sangmo Hong, Kyung‐Soo Kim, Kyungdo Han, et al.
European Heart Journal (2021) Vol. 43, Iss. 15, pp. 1491-1499
Closed Access | Times Cited: 37
Personalized Medical Treatment of Patients With Acromegaly: A Review
Dawn Shao Ting Lim, Maria Fleseriu
Endocrine Practice (2022) Vol. 28, Iss. 3, pp. 321-332
Closed Access | Times Cited: 24
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly
Sabrina Chiloiro, Stefano Frara, Irene Gagliardi, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 1, pp. e58-e68
Open Access | Times Cited: 15
Acromegaly and Bone: An Update
Andrea Giustina
Endocrinology and Metabolism (2023) Vol. 38, Iss. 6, pp. 655-666
Open Access | Times Cited: 15
Risk of cancer in acromegaly patients: An updated meta-analysis and systematic review
Zhehao Xiao, Pingping Xiao, Yong Wang, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0285335-e0285335
Open Access | Times Cited: 13
High mortality risk among women with acromegaly still persists
Simona Găloiu, Iustin-Daniel Toma, D. Tanasie, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 5
Genetic diagnosis in acromegaly and gigantism: From research to clinical practice
Claudia Ramírez‐Rentería, Laura C. Hernández‐Ramírez
Best Practice & Research Clinical Endocrinology & Metabolism (2024) Vol. 38, Iss. 3, pp. 101892-101892
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top